LATAM confirms expansion of cargo fleet with additional 767s
Major pharmaceutical transporter in Latin America will nearly double freighter capacity by 2023
In an effort to grow its freighter fleet, LATAM Group, a major transporter of pharmaceutical products in Latin America, plans to add 10 Boeing 767-300 Boeing Converted Freighters over the next three years. The first aircraft will be expected to begin operations in December.
LATAM’s freighter fleet growth plan originally consisted of four firm conversion orders with Boeing, along with another four conversion options. Two months after the initial announcement, LATAM has exercised the four options, eight planes and the conversion of two additional Boeing 767-300ERs—this brings the fleet size to up to 21 freighters by the end of 2023.
Growing from 11 to 21 freighter planes will enable LATAM's cargo subsidiaries to expand and reinforce their capacity to, from and within South America. The first eight airplanes have been assigned to markets that are crucial for key customer segments, the company notes.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
